Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

kelly smith

- PMLiVE

NICE promises UK to lead Europe for cancer drug approvals

But industry says running the new CDF will present NICE with a ‘hugely challenging’ task

- PMLiVE

J&J launches collaborative innovation initiative

Aims to fuel evolution of new industry models

- PMLiVE

Vectura to merge with SkyePharma in £441m deal

Will form a “one-stop shop” for specialist respiratory medicine development

- PMLiVE

First round to Amgen in PCSK9 patent battle with Sanofi

US court concludes Praluent has infringed rival cholesterol drug Repatha

- PMLiVE

Guiding decisions

How the ever-changing face of market research continues to impact the healthcare industry

Sexual selection

What happens in the interview room accelerates industry evolution

- PMLiVE

BMS appoints Peter Arduini to board of directors

He brings experience from Integra LifeSciences and Baxter Healthcare

- PMLiVE

Dr Niall Murphy and Pierre Schwich join Pharnext

They take up the roles of chief scientific officer and chief financial officer

Roche - Basel

Roche boosts cancer portfolio with $1bn Blueprint deal

Collaboration will focus on the development of its ‘immunokinases’ immuno-oncology treatment

- PMLiVE

Valeant shares slide on fears of filing default

Cuts revenue forecasts for 2016 following report of fourth-quarter loss

- PMLiVE

Social media and inflation penalties for generic drugs

US generic drug companies are under more scrutiny as the US public becomes more vocal 

- PMLiVE

Sally Waterman appointed as chair of OBN

She succeeds David Laskow-Pooley

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links